Testing effectiveness (Phase 2)Looking for participantsNCT06104228
What this trial is testing
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)+1 more
Bastiaan Driehuys 20